期刊名称：STEM CELLS
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
STEM CELLS., a peer-reviewed bimonthly journal, providesa forum for prompt publication of original investigativepapers and concise reviews. STEM CELLS is read and written by clinical and basic scientists whose expertise encompasses the rapidly expanding fields of stem and progenitor cell biology.
Stem Cells welcomes original articles and concise reviews describing basic laboratory investigations of stem cells and the translation of their clinical aspects of characterization and manipulation from the bench to patient care. It also provides a forum for young investigators to present provocative proposals for new research directions. The journal covers all aspects of stem cells: hematopoietic stem cell biology and the role of growth factors; translational research in blood and marrow transplantation; ex vivo expansion of PBPC and cord blood; stem cell plasticity; signal transduction in normal and malignant cells; molecular mechanisms of leukemogenesis; endothelial-hematopoietic cell interaction; gene expression and transcription factors.
Instructions to Authors
Information for Authors
General Information
Beginning in January 2009, STEM CELLS will be co-published by AlphaMed Press and Wiley-Blackwell.
STEM CELLS, the premier journal on stem cell biology, offers high visibility for your published research and maintains consistently high quality content dedicated to all aspects of stem cell research. Reasons to publish in STEM CELLS:
Enhanced Print and Online presentation ¨C beginning with the January 2009 issue, STEM CELLS will be offered on Wiley Interscience and HighWire, for easy and wider access, featuring a variety of new and dynamic online functionalities!
High quality content ¨C maintained through the same rigorous peer-review system as before and internationally renowned Editors and Editorial Advisory Board.
Rapid publication ¨C now posting accepted manuscripts online within 10 days of acceptance.
Enhanced discoverability for your paper ¨C generated through CrossRef Links (enabling users to move from a reference to your article) and email fTOCs (forthcoming Table of Contents) and eTOC (Table of Contents) Alerts and RSS Feeds sent to users on acceptance and publication of your paper.
Strong Impact Factor ¨C 2007 IF of 7.531 and listed in the Cellular Biology, Hematology, Oncology, and Biotechnology & Applied Microbiology categories of ISI.
Online submission ¨C Manuscript Central helps speed up the peer-review process.
John Wiley & Sons, Inc. offers authors the option of making their article available upon publication to non©\subscribers.
OnlineOpen is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of their article. With OnlineOpen the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made available to non-subscribers upon publication via Wiley InterScience, as well as deposited in the funding agency's preferred archive.
In addition to publication online via Wiley InterScience, authors of OnlineOpen articles are permitted to post the final, published PDF of their article on a website, institutional repository or other free public server, immediately on publication.
The prepaid charge for this service is $2,000, payable only in US Dollars: Download OnlineOpen Order Form
FAQs
How do I submit a manuscript to STEM CELLS?
The submission process has not changed. As before, manuscripts can be submitted using our online manuscript submission system by clicking on the following link http://mc.manuscriptcentral.com/stemcells and following the step-by-step instructions. Please click on the following links for instructions on the preparation of your manuscript and for the Aims & Scope of the journal.
What if I submitted my manuscript prior to the co-publication arrangement by AlphaMed Press and Wiley-Blackwell and am still waiting for a reply? Do I need to resubmit?
No. The decision on your manuscript will be processed without any disruption.
What if my manuscript has already been accepted for publication?
All accepted manuscripts will be published online and in print in a future issue of STEM CELLS on Wiley InterScience and HighWire. Full text of your article will be available in both HTML and PDF forms.
What if my manuscript was published in an issue of STEM CELLS prior to January 2009?
Back content of STEM CELLS will be available through HighWire and Wiley InterScience going back to 1996 (Volume 14).
Instructions for Authors
Online Manuscript Submission with STEM CELLS Manuscript Central
Track the progress of your manuscript as it moves through the peer-review processSave on mailing chargesAccelerate the time to acceptance3 Steps:
1. Please read the detailed manuscript submission instructions: Information for Authors
2. Click on the required forms you'll need to download and return:
STEM CELLS Potential Conflict of Interest Disclosure FormCopyright Transfer and Agreement Form Submission Fee Form
3. Then go to http://mc.manuscriptcentral.com/stemcells to submit your manuscript.
Adobe Acrobat® Reader™ is required to open the Information for Authors, as well as all supporting forms. Click here to download Adobe Acrobat® Reader™.
Word limits and figure maximums for each category:
(Excluding abstracts, tables, figures, legends and references)
Maximum 5,000 wordsMaximum of seven figures and tablesMaximum 250 word AbstractSpecific Questions:
Click here to send email to the Editorial Office.
For technical assistance in uploading your manuscript files, there is a "Get Help Now" button in Manuscript Central.
Other documents:
Permissions Information form
NIH Public Access Mandate
Wiley-Blackwell will support our authors by posting the accepted version of articles by NIH grant-holders to PubMed Central upon acceptance by the journal. The accepted version is the version that incorporates all amendments made during peer review, but prior to the publisher¡¯s copy-editing and typesetting. This accepted version will be made publicly available 12 months after publication. The NIH mandate applies to all articles based on research that has been wholly or partially funded by the NIH and that are accepted for publication on or after April 7, 2008.
NIH authors should be aware that they will receive an e-mail request once Wiley-Blackwell has posted the files of their accepted manuscript to the NIH Manuscript Submission system to approve the upload for display on the PubMed Central system. This is a requirement of their grant/affiliation.
For NIH employees only, we will accept the NIH Publishing Agreement.
The societies for whom we publish may decide on a different policy. We will continue to brief them on any discussions that we have with the NIH regarding the processing of the articles, appropriate acknowledgements with citation and linking to the final published version on the publisher¡¯s site, and clear licensing terms and conditions for the use of copyrighted material.
In addition, Wiley-Blackwell will continue to consult directly with authors, editors and society partners to determine how we as their publisher may best support them going forward.
Reprints and Permissions
COPYRIGHT NOTICE
STEM CELLS® (pISSN 1066-5099) and STEM CELLS Online (eISSN-1549-4918) and all contributions included therein are protected by copyright. All rights are reserved under United States and international copyright laws and other applicable laws and conventions. No copyright is claimed in any original work created by agencies or employees of the United States government.
No part of this publication may be reproduced or transmitted in any form without the prior written consent of AlphaMed Press or Copyright Clearance Center. Certain provisions of the Copyright Act of 1976, as amended, respecting fair use and reproduction by libraries and archives, 17 U.S.C. ¡ì¡ì 107 and 108, may be applicable.
--------------------------------------------------------------------------------
REPRINTS
Author and Corporate Reprints are available, with covers or other customized marketing information. To order, contact Gale Krouser, Reprint Representative, Wiley-Blackwell, John Wiley & Sons Inc., 111 River St., Hoboken, NJ 07030-5774 USA. Email: gkrouser@wiley.com; Tel: +1 201-748-8789. Please include the following information:
Title of the Article.Author(s) of the Article.Volume and Number of STEM CELLS in which the article appeared.Number of reprints requested (minimum order is 100).Your preference of service: Economy service requires approximately 15 working days; or Priority service requires only 5 working days.--------------------------------------------------------------------------------
PERMISSIONS
Procedure to Request Permission
Permission requests, as described below, to photocopy, distribute, and republish material from STEM CELLS should be directed to the Copyright Clearance Center (CCC):
Classroom handoutsPrint and electronic coursepacksInterlibrary loanLibrary reservesBusiness purposes (sharing information with investors, prospects, clients, and partners)Republish figures, tables, abstracts, or excerpts in another book, journal, or newsletterRepublish figures, tables, abstracts, or excerpts in a brochure or pamphletUse of figures, tables, abstracts, or excerpts in PowerPointUse of figures, tables, abstracts, or excerpts in a dissertation or thesis paper
The CCC will grant requests only to reproduce our material exactly as it was originally published. You can submit your request to the CCC via traditional mail, fax, or email. Additionally, you can secure permission online using their automated online system. Submit requests to:
Traditional mail: CCC, 222 Rosewood Drive, Danvers, Massachusetts 01923, USA
Telephone: 978-750-8400 (8:00 am-5:30 pm EST)
Fax: 978-646-8600
Email: info@copyright.com
Online: www.copyright.com
All other permission requests should be made in writing to the Permissions Department, c/o John Wiley & Sons, Inc., 111 River Street, Hoboken, NJ 07030: (201) 748-6011, fax (201) 748-6008, E-mail: permreq@wiley.com, and should include a statement of intended use, as well as explicit specifications of the materials to be reproduced. When submitting your permission request, please include the following information:
A complete citation of the requested material (title of journal, volume number, issue number, year, author name, article title, specific page numbers)The intended use of the material (for publication, slides, handouts, etc.)If for handouts: the number of copies being madeIf for republication: the publisher and the name of the new publicationHow the material will be reproduced and distributedComplete contact details (name, institution/company name, address, telephone, fax, email)Internet sites interested in linking to information published by John Wiley & Sons must submit a written request and include the following information: Originating website URL, company business focus, complete contact information, and description of the specific page or material to be linked.
Authors
As an author, you are granted rights for a large number of author uses, including use by your employing institute or company. These rights are granted and permitted without the need to obtain specific permission from AlphaMed Press, provided a full credit line is prominently placed (i.e., author name(s), journal name, copyright year, volume number, inclusive pages, and copyright holder). The author rights include:
the right to make copies of the article for your own personal use, including for your own classroom teaching use;the right to make copies and distribute copies (including through email) of the article to research colleagues, for the personal use by such colleagues (but not commercially or systematically, e.g., via an email list or list serve);the right to present the article at a meeting or conference and to distribute copies of such paper or article to the delegates attending the meeting;for the author¡¯s employer, if the article is a ¡°work for hire,¡± made within the scope of the author¡¯s employment, the right to use all or part of the information in (any version of) the article for other intra-company use (e.g., training);patent and trademark rights and rights to any process or procedure described in the article;the right to include the article in full or in part in a thesis or dissertation (provided that this is not to be published commercially);the right to use the article or any part thereof in a printed compilation of works of the author, such as collected writings or lecture notes (subsequent to publication of the article in the journal);the right to prepare other derivative works, to extend the article into book-length form, or to otherwise reuse portions or excerpts in other works, with full acknowledgment of its original publication in the journal; andthe right to post their work as the final peer-reviewed author¡¯s manuscript (but not published layout) on their own website, their institution¡¯s website (website only, NOT repository), and their funding body¡¯s archive, provided a link is made to the STEM CELLS version.Wellcome Trust-Funded Articles
Since October 1, 2006, Wellcome Trust grantees are required to submit an electronic copy of the final manuscripts of their research papers to PMC or UKPubMed Central (UKPMC). The Wellcome Trust requires that the author¡¯s work be made available to the public via PMC and PMC mirror sites no later than six months after final publication. AlphaMed Press and Wiley-Blackwell have established a policy that will allow authors who publish in STEM CELLS to comply with these requirements.
AlphaMed Press and Wiley-Blackwell authorize Wellcome Trust-funded authors whose papers are accepted and published in STEM CELLS permission to deposit the author¡¯s peer-reviewed manuscript (but not published format) in PMC and UKPMC no earlier than six months after the print publication in STEM CELLS. Additionally, the author is authorized to replace the peer-reviewed author manuscript with the final published version 12 months after print publication in STEM CELLS. Further information on the Wellcome Trust policy is available at: http://www.wellcome.ac.uk/node3302.html .
Editorial Board
EDITORIAL BOARD
CO-EDITORS
Donald G. Phinney
Professor o Microbiology and Immunology
Associate Director of Research
Center for Gene Therapy
Tulane University
Rm 672, J. Bennett Johnston Building
(SL-99) 1430 Tulane Avenue
New Orleans, LA 70112
Miodrag Stojković
Deputy Director
Centro de Investigacion Principe Felipe
Head of Cellular Reprogramming Laboratory
C/E.P. Avda. Autopista del Saler
16-3 (junto Oceanografico)
46013 Valencia
Spain
CORRESPONDENCE
Editorial correspondence should be addressed to Executive Editor .
Information for Authors can be found at www.StemCells.com, or contacting the Editorial Office..
| 
刊名字顺( Alphabetical List of Journals):
返回页首 